Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1HP vs 3HP for Latent Tuberculosis Infection
NCT04094012Phase 3Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Sep 2019
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of isoniazid, rifapentine in latent tuberculosis infection (LTBI), sponsored by National Taiwan University Hospital. Started Sep 2019; status: completed.
02
Drugs
isoniazidrifapentine
03
Conditions
latent tuberculosis infection (LTBI)
Beyond the preview
Go deeper on NCT04094012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04094012.